Currently out of the existing stock ratings of John Young, 13 are a HOLD (31.71%), 28 are a BUY (68.29%).

John Young

Work Performance Price Targets & Ratings Chart

Analyst John Young, currently employed at CANACCORD, carries an average stock price target met ratio of 39.58% that have a potential upside of 26.47% achieved within 75 days.

John Young’s has documented 80 price targets and ratings displayed on 2 stocks. The coverage is on the Healthcare sector.

Most recent stock forecast was given on STAA, STAAR Surgical Company at 14-May-2026.

Wall Street Analyst John Young

Analyst best performing recommendations are on STAA (STAAR SURGICAL COMPANY).
The best stock recommendation documented was for STAA (STAAR SURGICAL COMPANY) at 2/27/2024. The price target of $32 was fulfilled within 1 day with a profit of $0.68 (2.08%) receiving and performance score of 20.81.

Average potential price target upside

LUNG Pulmonx Corp STAA STAAR Surgical Company

Analyst name

Rating

Current price target

Potential Upside

Previous price target

Date of last PT

Price targets met ratio

Average potential upside

Average Days to Hit Target

Performance score

Buy Since 31-Oct-2023

$5

$3.75 (300.00%)

$15

Buy Since 04-Jun-2024

$4

$2.75 (220.00%)

$12

Buy Since 26-Oct-2020

$5

$3.75 (300.00%)

$16

Show more analysts

Please expand the browser size to see the chart

Which stock is John Young is most bullish on?

Potential upside of $8.86 has been obtained for STAA (STAAR SURGICAL COMPANY)

Which stock is John Young is most reserved on?

Potential downside of -$0.78 has been obtained for MMSI (MERIT MEDICAL SYSTEMS)

What Year was the first public recommendation made by John Young?

On 2023

To continue looking at which analysts cover the stock please register to the basic or advanced membership

What is AnaChart?